Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The objective of this clinical study is to compare the safety and efficacy of Mapracorat
Ophthalmic Suspension, 3% to vehicle for the treatment of postoperative inflammation and pain
following cataract surgery.